Earnings summaries and quarterly performance for Cboe Global Markets.
Executive leadership at Cboe Global Markets.
Board of directors at Cboe Global Markets.
Alexander J. Matturri, Jr.
Detailed
Director
Cecilia H. Mao
Detailed
Director
Edward J. Fitzpatrick
Detailed
Director
Erin A. Mansfield
Detailed
Director
Ivan K. Fong
Detailed
Director
James E. Parisi
Detailed
Director
Janet P. Froetscher
Detailed
Director
Jennifer J. McPeek
Detailed
Director
Jill R. Goodman
Detailed
Director
Roderick A. Palmore
Detailed
Director
William M. Farrow, III
Detailed
Chairman
Research analysts who have asked questions during Cboe Global Markets earnings calls.
Alex Kramm
UBS Group AG
4 questions for CBOE
Also covers: BR, CBRE, CME +15 more
Daniel Fannon
Jefferies Financial Group Inc.
4 questions for CBOE
Also covers: AB, AMG, AMTD +27 more
Kwun Sum Lau
Oppenheimer
4 questions for CBOE
Also covers: CLVT, CME, COIN +9 more
Patrick Moley
Piper Sandler & Co.
4 questions for CBOE
Also covers: BGC, CME, COIN +17 more
Alexander Blostein
Goldman Sachs
3 questions for CBOE
Also covers: AB, AMG, AMP +31 more
Ashish Sabadra
RBC Capital Markets
3 questions for CBOE
Also covers: ADP, CLVT, CME +20 more
Benjamin Budish
Barclays PLC
3 questions for CBOE
Also covers: AB, APO, ARES +23 more
Craig Siegenthaler
Bank of America
3 questions for CBOE
Also covers: AB, AMP, AMTD +26 more
Kenneth Worthington
JPMorgan Chase & Co.
3 questions for CBOE
Also covers: APO, ARES, BAM +27 more
Kyle Voigt
Keefe, Bruyette & Woods
3 questions for CBOE
Also covers: AMTD, APO, ARES +17 more
Brian Bedell
Deutsche Bank
2 questions for CBOE
Also covers: AMG, AMTD, APO +22 more
Christopher Allen
Citigroup
2 questions for CBOE
Also covers: CME, ETOR, HOOD +9 more
Michael Cyprys
Morgan Stanley
2 questions for CBOE
Also covers: AAMI, AMP, AMTD +30 more
Anthony Carbon
Goldman Sachs Group Inc.
1 question for CBOE
Ben Budish
Barclays PLC
1 question for CBOE
Also covers: AB, APO, ARES +19 more
Eli Abboud
Bank of America
1 question for CBOE
Also covers: BGC, CME, MKTX +2 more
Jeffrey Schmitt
William Blair
1 question for CBOE
Also covers: AIZ, AMP, FTDR +8 more
Stephanie Ma
Morgan Stanley
1 question for CBOE
Also covers: GCMG, HLNE, PX
William Katz
TD Cowen
1 question for CBOE
Also covers: AB, AMG, AMTD +25 more
Recent press releases and 8-K filings for CBOE.
Cboe Global Markets launches 21Shares XRP ETF (TOXR)
CBOE
Product Launch
- 21Shares XRP ETF (TOXR) launched on Cboe with a 0.30% TER.
- Not registered under the Investment Company Act of 1940, TOXR carries heightened volatility and significant risk and is not a direct XRP investment.
- Employs a multi-custody model with Coinbase, Anchorage Digital Bank, and BitGo to safeguard assets.
- Flow Traders acts as lead market maker, providing liquidity for TOXR shares.
- Since entering the US market in 2022, 21Shares has grown to >$8 billion AUM across five ETPs as of November 2025.
4 days ago
Cboe outlines strategic realignment and growth initiatives at Goldman Sachs U.S. Financial Services Conference
CBOE
Share Buyback
Guidance Update
- Cboe will divest its Australia, Canada and Japan securities trading businesses, targeting completion in 2026 to refocus on core U.S. derivatives and equities growth areas.
- CFO Jill Griebenow expects these divestitures to reduce consolidated net revenue by 3% and deliver 8–10% in phased expense savings off a 2025 base.
- The SPX options franchise, led by 0DTE, is growing rapidly—retail and institutional usage now roughly 50/50, with ~200,000 five-delta spreads traded daily—driving SPX complex market share to the mid-70s%.
- Data Vantage revenue guidance for 2025 was raised to high single to low double digits, with 90% of Q3 net revenue growth from new unit additions.
- Cboe maintains $1.5 billion in cash as of September 30 and will continue an opportunistic share buyback program while redeploying proceeds into core priorities.
6 days ago
Cboe outlines 2026 strategic realignment and growth priorities
CBOE
Revenue Acceleration/Inflection
New Projects/Investments
Share Buyback
- Cboe plans to divest its Japan, Australia and Canada businesses largely in 2026, expecting a 3% reduction in net revenue and 8–10% in expense savings on the 2025 base, with proceeds to be reinvested into core growth areas.
- The SPX options complex, led by zero DTE, has seen 20% annual growth in 2025 and now comprises ~60% of SPX ADV, with institutional participation rising toward 50%.
- The firm will build event and prediction markets for economic and securities-related contracts (not sports) organically, leveraging its SPX/zero DTE infrastructure and focusing on product integrity and customer education.
- Data Vantage revenue guidance was raised to high single–low double digits for 2025, driven 90% by new unit additions (e.g., dedicated cores, timestamping enhancements).
- Cboe holds $1.5 billion in cash (as of Sep 30), will remain opportunistic on share buybacks, and sees no material M&A in the near term.
6 days ago
Cboe Global Markets reports November 2025 trading volumes
CBOE
- Cboe’s average daily trading volume in November 2025 rose 16.8% YoY to 14.43 million multi-listed options contracts and 41.4% YoY to 5.86 million index options contracts.
- U.S. equities on-exchange ADV reached 1.802 billion shares (+12.5% YoY) and off-exchange ADV was 202 million shares (+115.0% YoY).
- European equities ADV was €12.772 billion (+13.4% YoY) and Global FX ADV hit $53.120 billion (+7.2% YoY).
- Cboe set new monthly ADV records in its proprietary index options suite: 5.9 million overall contracts, 4.6 million SPX options, and 2.8 million SPX 0DTE options.
Dec 3, 2025, 9:59 PM
Cboe to offer nearly 24-hour trading for Russell 2000 options
CBOE
Product Launch
- Nearly 24x5 trading: Cboe will extend Russell 2000 Index (RUT) options trading to nearly 24 hours a day, five days a week, by adding a Global Trading Hours overnight session starting February 9, 2026.
- Extended hours: RUT options will trade from 8:15 p.m. ET to 9:25 a.m. ET in GTH, complementing the existing 9:30 a.m.–4:15 p.m. ET session.
- Volume growth: As of end-November 2025, average daily RUT options volume reached ~75,000 contracts, up 66% vs. full-year 2022, reflecting strong global demand.
- Global access: Expanded hours aim to help investors worldwide respond to market events and manage U.S. small-cap exposure more effectively.
Dec 2, 2025, 11:45 PM
Cboe Global Markets to launch Magnificent 10 Index futures and options
CBOE
Product Launch
- Cboe Global Markets will begin trading futures and options on the Cboe Magnificent 10 Index (MGTN) on December 8, 2025.
- The equal-weighted index, launched October 14, 2025, tracks the price return of 10 large-cap U.S. tech and growth stocks.
- Both products are cash-settled: futures will trade on Cboe Futures Exchange with a.m. settlement; options will trade on Cboe Options Exchange under tickers MGTN (AM-settled) and MGTNW (PM-settled) with a $100 multiplier.
- MGTN futures will be available nearly 24 hours a day at launch, and Cboe plans to offer global trading hours for MGTN options in early 2026.
Nov 18, 2025, 3:00 PM
Cboe Global Markets to Launch Bitcoin and Ether Continuous Futures on December 15, 2025
CBOE
Product Launch
- Cboe Futures Exchange to begin trading Cboe Bitcoin Continuous Futures (PBT) and Cboe Ether Continuous Futures (PET) on December 15, 2025, subject to regulatory review.
- The contracts offer U.S.-regulated perpetual-style exposure with a 10-year expiration and daily cash adjustments to align futures and spot prices.
- Continuous Futures will be centrally cleared by Cboe Clear U.S., trade on a 23×5 schedule, and use the Cboe Kaiko Real-Time Rate for settlement.
- Investors can leverage streamlined rolling, potential cross-margining with existing CFE products (e.g., FBT, FET), and attend educational sessions on December 17, 2025 and January 13, 2026.
Nov 17, 2025, 3:00 PM
Cybin reports Q2 FY2026 results and business highlights
CBOE
Earnings
New Projects/Investments
- Closed a US$175 million registered direct offering, resulting in US$248 million in cash as of September 30, 2025, and retired all outstanding convertible debentures.
- Q2 FY2026 net loss of US$33.7 million, versus US$41.9 million year-over-year; cash-based operating expenses were US$28.5 million, and operating cash outflow was US$34.5 million.
- Completed enrollment in Phase 2 CYB004 for GAD (topline data due Q1 2026) and advanced Phase 3 CYB003 studies (APPROACH dosing ongoing; topline data expected Q4 2026).
Nov 13, 2025, 12:20 PM
Cboe Global Markets reports October 2025 trading volume
CBOE
- Cboe set a monthly record for total U.S. options ADV at 21.4 million contracts, driven by 15.9 million multi-listed options (+47.2% Y/Y) and 5.5 million index options (+38.6% Y/Y).
- S&P 500 Index (SPX) options reached new highs with a monthly ADV of 4.4 million, 0DTE options ADV of 2.7 million, and a single-day record of 6.4 million contracts.
- Across other asset classes, U.S. on-exchange equities ADV rose 56.7% Y/Y to 2.02 billion shares, while global FX ADV reached $55.1 billion (+24.3% Y/Y).
Nov 5, 2025, 9:30 PM
Cboe Global Markets reports Q3 2025 earnings
CBOE
Earnings
Revenue Acceleration/Inflection
- Cboe delivered $605.5 million in Q3 2025 net revenue, up 14% year-over-year.
- Adjusted operating EBITDA was $409.0 million (+21% y/y) with a 67.5% margin, and adjusted diluted EPS reached $2.67 (+20% y/y).
- By segment, Derivatives markets net revenue grew 15% (Options up 19%), Data Vantage rose 12%, Cash & Spot increased 14%, and Global FX was up 13%.
- Futures net revenue declined 22%, driven by a 27% drop in average daily volume.
Oct 31, 2025, 12:30 PM
Quarterly earnings call transcripts for Cboe Global Markets.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more